Marcin Hachuła

Medical University of Silesia

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Robert Krysiak

Medical University of Silesia

POLAND

View details

Marcin Basiak

Adjunct (Assistant Professor)

Medical University of Silesia

POLAND

View details

Grzegorz Machnik

Medical University of Silesia

POLAND

View details

Michał Holecki

Head of Department/Professor, MD, PhD

Medical University of Silesia School of Medicine in Katowice

POLAND

View details

Mateusz Maligłówka

Medical University of Silesia

POLAND

View details

Bogusław Okopień

Medical University of Silesia

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marcin Hachuła

Research Interests

Explore related searches

Contact this professor

Articles (15)

The Crucial Question About Contrast-Induced Nephropathy (CIN): Should It Affect Clinical Practice?

Effect of GLP-1RA treatment on adhesion molecules and Monocyte Chemoattractant Protein-1 in diabetic patients with atherosclerosis.

Impact of glucagon-like peptide 1 receptor agonists on biochemical markers of the initiation of atherosclerotic process.

Influence of dulaglutide on serum biomarkers of atherosclerotic plaque instability: an interventional analysis of cytokine profiles in diabetic subjects - a pilot study.

Initial clinical, laboratory and radiological features of SARS-CoV-2-infected patients and their impact on the course of the disease

Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes—Interventional Study

The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods

The Impact of Various Methods of Obesity Treatment on the Quality of Life and Mental Health—A Narrative Review

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque

Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque

Plasma Concentrations of New Biochemical Markers of Atherosclerosis in Patients with Dyslipidemia—A Pilot Study

Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia

Plasma Concentrations of Cytokines in Patients with Combined Hyperlipidemia and Atherosclerotic Plaque before Treatment Initiation—A Pilot Study

Fungal infection mimicking COVID-19 infection – A case report

Does prior SARS-CoV-2 infection increase the risk of adverse effects after mRNA vaccination (BNT162b2) - the retrospective cohort study of physicians.

Collaborators (6)

Robert Krysiak

Marcin Basiak

Grzegorz Machnik

Michał Holecki

Mateusz Maligłówka

Bogusław Okopień

Make your next move.